[Nirmatreolvir-ritonavir (Paxlovid) leads to no reduction of symptoms or hospitalizations in vaccinated or unvaccinated high-risk adults with Covid-19.].

Recenti Prog Med

Dipartimento di Cure primarie, Ausl Modena, Italia - Dipartimento di Scienze biomediche, metaboliche e neuroscienze, Università di Modena e Reggio Emilia, Modena, Italia.

Published: September 2024

Download full-text PDF

Source
http://dx.doi.org/10.1701/4334.43178DOI Listing

Publication Analysis

Top Keywords

[nirmatreolvir-ritonavir paxlovid
4
paxlovid leads
4
leads reduction
4
reduction symptoms
4
symptoms hospitalizations
4
hospitalizations vaccinated
4
vaccinated unvaccinated
4
unvaccinated high-risk
4
high-risk adults
4
adults covid-19]
4

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!